In re: Unique Third Avenue LLC, et al.

CourtUnited States Bankruptcy Court, S.D. New York
DecidedJanuary 8, 2026
Docket25-12461
StatusUnknown

This text of In re: Unique Third Avenue LLC, et al. (In re: Unique Third Avenue LLC, et al.) is published on Counsel Stack Legal Research, covering United States Bankruptcy Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re: Unique Third Avenue LLC, et al., (N.Y. 2026).

Opinion

UNITED STATES BANKRUPTCY COURT SOUTHERN DISTRICT OF NEW YORK FOR PUBLICATION In re: Chapter 11 Unique Third Avene LLC, et al.,1 Case No. 25-12461 (JPM) Debtors. Jointly Administered

APPEARANCES

BACKENROTH FRANKEL & KRINSKY, LLP Counsel for the Debtors 488 Madison Ave., 23rd Floor New York, NY 10022 By: Mark A. Frankel

CHAPMAN AND CUTLER LLP Counsel for Creditor Bank of America, N.A. 1270 Avenue of the Americas, 30th Floor New York, NY 10020 By: J. Alex Kress

UNITED STATES TRUSTEE Office of the U.S. Trustee, Region 2 Alexander Hamilton Custom House One Bowling Green, Room 534 New York, NY 10004 By: Annie Wells

MEMORANDUM OPINION AND ORDER DENYING DEBTORS’ MOTION FOR DETERMINATION THAT THE APPOINTMENT OF A PATIENT CARE OMBUDSMAN IS NOT NECESSARY

1 The consolidated cases are: In re Unique Third Avenue LLC, No. 25-12461 (JPM) (Bankr S.D.N.Y. filed Nov. 13, 2025); In re Third Avenue Imaging LLC, No. 25-12462 (JPM) (Bankr. S.D.N.Y. filed Nov. 13, 2025); In re Unique Imaging Services LLC, No. 25-12463 (JPM) (Bankr. S.D.N.Y. filed Nov. 13, 2025); and In re Distinguished Diagnostic Imaging, P.C., No. 25-12464 (JPM) (Bankr. S.D.N.Y. filed Nov. 13, 2025). JOHN P. MASTANDO III UNITED STATES BANKRUPTCY JUDGE

I. INTRODUCTION This is a jointly administered Chapter 11 case of the debtors Unique Third Avenue LLC (“UTA”), Third Avenue Imaging LLC (“TAI”), Unique Imaging Services LLC (“UIS”), and Distinguished Diagnostic Imaging, P.C. (“DDI”) (collectively, the “Debtors”). Before the Court is the Debtors’ motion (the “Motion”), dated November 13, 2025, seeking a determination that the appointment of a patient care ombudsman is unnecessary. (Dkt. No. 12). On December 12, 2025, the United States Trustee (the “Trustee”) filed an objection (the “Objection”). (Dkt. No. 31). The Trustee argues that, absent an ombudsman, the quality of the Debtors’ healthcare services may deteriorate to the detriment of patients, and that the Debtors have failed to demonstrate the existence of a substitute program to safeguard patient welfare. (Id.) A hearing on the Motion was held on December 19, 2025 (the “Hearing”). At the Hearing, Bank of America, N.A. (the “Bank”) appeared and stated its support for the Trustee’s Objection. The Court has reviewed all relevant filings, the arguments presented at the Hearing, and the record as a whole. For the reasons set forth below, the Motion is DENIED. II. BACKGROUND A. FACTUAL BACKGROUND The Debtors are related corporate entities with principal offices in the South Bronx, New

York. (Dkt. No. 1). They collectively operate a physician-based diagnostic imaging business providing X-ray, MRI, and mammography services, and are licensed by the New York State Department of Health. (Dkt. No. 31, ¶ 6). In February 2017, the Bank extended a $5,240,000 term loan to TAI (the “TAI Loan”) and a $4,960,000 term loan to UTA (the “UTA Loan”). (Dkt. No. 20, ¶ 1). In connection with those loans, the Debtors granted the Bank a first-priority lien on substantially all business assets and a mortgage on certain UTA real property in Bronx County. (Dkt. No. 13, ¶ 3; Dkt. No. 20, ¶¶ 1, 13). Each Debtor guaranteed the obligations. (Dkt. No. 20, ¶ 2). On November 1, 2019, the Debtors defaulted on the TAI Loan. (Dkt. No. 20, ¶ 1). In a

subsequent federal diversity action, the U.S. District Court for the Southern District of New York (the “District Court”) granted summary judgment for the Bank on June 5, 2023, holding that TAI breached the loan agreement and that the co-Debtors were jointly and severally liable under their guaranties. See Bank of America, N.A. v. Third Avenue Imaging LLC, No. 21-cv-5201-VB (S.D.N.Y. June 5, 2023) (Dkt. No. 88). On March 8, 2024, the District Court entered judgment in the amount of $2,699,933.82 against TAI, UTA, UIS, and its principal owner Joel Reisman, and $3,119,263.07 against DDI. (Dkt. No. 20, ¶ 2). Separately, on April 5, 2023, the Bank commenced a foreclosure action against UTA in the Supreme Court of the State of New York, Bronx County (the “State Court”). See Bank of America N.A. v. Unique Third Ave. LLC, et al., No. 805445-2023E (N.Y. Sup. Bronx Cty. Apr. 5, 2023).

(Dkt. No. 20, ¶ 3). On July 10, 2025, the State Court granted summary judgment for the Bank. (Id.) On October 29, 2025, the referee in the foreclosure proceeding filed a report calculating the Debtors’ obligation to the Bank at $6,684,696.61, plus interest, arising from the defaults on the UTA Loan. (Id.) B. PROCEDURAL POSTURE AND PARTIES’ ARGUMENTS On November 4, 2025, each of the Debtors filed a voluntary Chapter 11 petition in this Court. (Dkt. No. 1). No trustee has been appointed; the Debtors retain control of their businesses and estate assets as debtors-in-possession. (Id.) On November 5, 2025, the Court ordered joint administration of the four cases under the above-captioned case number. (Dkt. No. 4). In their schedules, the Debtors report the Bank as holding a secured claim of $11,429,935.00, supported by collateral valued at $3,261,747.00. (Dkt. No. 1, Schedule D). The Bank is scheduled as UTA’s sole secured creditor, while TAI, UIS, and DDI each scheduled secured creditors other than the Bank. (Id.)

On November 13, 2025, the Debtors filed the instant Motion. (Dkt. No. 12). The Motion seeks entry of an order “finding that the appointment of a patient care ombudsman is not necessary” under 11 U.S.C. § 333. (Id.) The Debtors contend that an ombudsman is unnecessary because the Debtors’ operations “present no risk to patient health or safety,” emphasizing that their “imaging process is non-invasive, brief, performed by licensed technologists under established protocols,” and do not involve “anesthesia, controlled substances, or emergency procedures[.]” (Id. ¶¶ 11-12). The Debtors further submit the declaration of their chief revenue officer, Mr. Nik Lavrinoff, who attests that the Debtors “perform only diagnostic imaging [without] ongoing treatment,” that “all patient data are stored off-site on encrypted servers maintained by a HIPAA-complaint vendor,” and that the “operations [have] continue[d] uninterrupted.” (Id. ¶ 18). Against this backdrop, the

Debtors argue that appointing an ombudsman “would impose unnecessary administrative expense with no discernable corresponding benefit to patient welfare.” (Id. ¶ 17). The Trustee objects, asserting that the Debtors have not met their burden to demonstrate that appointment is unnecessary under § 333. (Dkt. No. 31). The Trustee advances three principal arguments. First, it contends that the Debtors understate the clinical judgment and medical risks involved by painting “a false picture that people are simply being shuffled in and out of machines, with no information taken, evaluations made, or medical skills required.” (Id. at 2). Second, the Trustee argues that the Debtors’ descriptions of their operations contradict representations on the Debtors’ own website, which indicate that their staff obtain detailed medical histories and engage in evaluative processes beyond mere imaging. (Id.) Third, the Trustee maintains that the Debtors’ assertion that their Chapter 11 filings are “purely financial” and will not affect patient safety is an “ex ante[,] conclus[ory]” statement “of no evidentiary value.” (Id.) III. LEGAL STANDARD Section 333(a)(1) of the Bankruptcy Code provides: If the debtor in a case under chapter 7, 9 or 11 is a health care business, the court shall order, not later than 30 days after the commencement of the case, the appointment of an ombudsman to monitor the quality of patient care and to represent the interests of the health care business unless the court finds that the appointment of such ombudsman is not necessary for the protection of patients under the specific facts of the case. 11 U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re William L. Saber, Md, Pc
369 B.R. 631 (D. Colorado, 2007)
In Re Alternate Family Care
377 B.R. 754 (S.D. Florida, 2007)
In Re Banes
355 B.R. 532 (M.D. North Carolina, 2006)
In Re Medical Associates of Pinellas, L.L.C.
33 A.L.R. Fed. 2d 769 (M.D. Florida, 2007)
In Re 7-Hills Radiology, LLC.
350 B.R. 902 (D. Nevada, 2006)
Pfizer, Inc. v. HHS
42 F.4th 67 (Second Circuit, 2022)
In re Valley Health System
381 B.R. 756 (C.D. California, 2008)
In re Flagship Franchises of Minnesota, LLC
484 B.R. 759 (D. Minnesota, 2013)
In re Smiley Dental Arlington, PLLC
503 B.R. 680 (N.D. Texas, 2013)
In re Pediatrics at Whitlock, P.C.
507 B.R. 10 (N.D. Georgia, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
In re: Unique Third Avenue LLC, et al., Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-unique-third-avenue-llc-et-al-nysb-2026.